Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamar Green

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|June 9, 2012
The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trialTamar Green, Lital Steingart, Amos Frisch, et al.
Developmental Medicine and Child Neurology|March 22, 2025
A familial modeling framework for advancing precision medicine for children with neuropsychiatric disordersJennifer L Bruno, Jacob Joseph Merrin, S M Hadi Hosseini, et al.
Brain Research|February 27, 2007
Hemisphere asymmetry in schizophrenia as revealed through line bisection, line trisection, and letter cancellationAri Z Zivotofsky, Shany Edelman, Tamar Green, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 6, 2017
X-Chromosome Effects on Attention Networks: Insights from Imaging Resting-State Networks in Turner SyndromeTamar Green, Manish Saggar, Alexandra Ishak, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 29, 2026
T1w/T2w ratio as an in vivo proxy for reduced intracortical myelin content in youth with RASopathies: a cross-sectional studyJulia R Plank, Sara K Pardej, Mira M Raman, et al.
Biological Psychiatry|October 4, 2024
Social Communication in Ras Pathway Disorders: A Comprehensive Review From Genetics to Behavior in Neurofibromatosis Type 1 and Noonan SyndromeMonica Siqueiros-Sanchez, Yaffa Serur, Chloe A McGhee, et al.
Molecular Psychiatry|January 28, 2022
Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathwayJennifer L Bruno, Sharon B Shrestha, Allan L Reiss, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
T1w/T2w ratio suggests reduced intracortical myelin content in youth with RASopathiesJulia R Plank, Sara K Pardej, Mira M Raman, et al.
International Clinical Psychopharmacology|December 6, 2012
Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective studyRafael Stryjer, Yael Dambinsky, Igor Timinsky, et al.
Clinical Neuropharmacology|May 15, 2014
Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label studyRafael Stryjer, Dana Budnik, Tania Ebert, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Journal of Neural Transmission (Vienna, Austria : 1996)|June 9, 2012
The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trialTamar Green, Lital Steingart, Amos Frisch, et al.
Developmental Medicine and Child Neurology|March 22, 2025
A familial modeling framework for advancing precision medicine for children with neuropsychiatric disordersJennifer L Bruno, Jacob Joseph Merrin, S M Hadi Hosseini, et al.
Brain Research|February 27, 2007
Hemisphere asymmetry in schizophrenia as revealed through line bisection, line trisection, and letter cancellationAri Z Zivotofsky, Shany Edelman, Tamar Green, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 6, 2017
X-Chromosome Effects on Attention Networks: Insights from Imaging Resting-State Networks in Turner SyndromeTamar Green, Manish Saggar, Alexandra Ishak, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 29, 2026
T1w/T2w ratio as an in vivo proxy for reduced intracortical myelin content in youth with RASopathies: a cross-sectional studyJulia R Plank, Sara K Pardej, Mira M Raman, et al.
Biological Psychiatry|October 4, 2024
Social Communication in Ras Pathway Disorders: A Comprehensive Review From Genetics to Behavior in Neurofibromatosis Type 1 and Noonan SyndromeMonica Siqueiros-Sanchez, Yaffa Serur, Chloe A McGhee, et al.
Molecular Psychiatry|January 28, 2022
Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathwayJennifer L Bruno, Sharon B Shrestha, Allan L Reiss, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
T1w/T2w ratio suggests reduced intracortical myelin content in youth with RASopathiesJulia R Plank, Sara K Pardej, Mira M Raman, et al.
International Clinical Psychopharmacology|December 6, 2012
Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective studyRafael Stryjer, Yael Dambinsky, Igor Timinsky, et al.
Clinical Neuropharmacology|May 15, 2014
Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs-an open-label studyRafael Stryjer, Dana Budnik, Tania Ebert, et al.
Pageof 8